CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin
about
Comprehensive annotation of bidirectional promoters identifies co-regulation among breast and ovarian cancer genesEpigenetic changes of DNA repair genes in cancerSusceptibility pathways in Fanconi's anemia and breast cancerFancf-deficient mice are prone to develop ovarian tumoursPromoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian CancerThe Fanconi anemia pathway and ubiquitinA hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions.An unsupervised learning approach to find ovarian cancer genes through integration of biological dataThe ubiquitin system, disease, and drug discovery.MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysisAn epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineMining to find the lipid interaction networks involved in Ovarian CancersKras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian populationThe Fanconi anemia pathway and ICL repair: implications for cancer therapy.Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.Epigenetic targeting in breast cancer: therapeutic impact and future direction.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway.Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer.Fanconi anaemia: from a monogenic disease to sporadic cancer.DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1.Disruption of the FA/BRCA pathway in bladder cancer.Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cellsFanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancerLow incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.Transcriptional regulation by RUNX3Current and emerging therapeutic strategies for Fanconi anemia.Guido Fanconi (1892-1979): a jack of all trades.Folate deficiency and aberrant DNA methylation and expression of FHIT gene were associated with cervical pathogenesis.Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma.
P2860
Q21145667-F5413E19-6F55-4569-90A5-B97946692900Q22242858-49A3EF5B-68D1-4288-8F8C-A0E4279567B4Q24628760-DE9B024B-D836-4ABB-A3C2-998D1AFD8781Q28247935-DC843064-4455-440C-A6DD-E62502B0423DQ28269159-1502436B-B39D-4650-B565-72E531D229B0Q28756516-480E025A-E82A-41EB-B787-2D8EFB08E732Q30494435-74031517-860B-4473-A9A6-6876B06E8447Q30990983-6E9E48CF-7C37-486A-A235-A87DA47F8C15Q33384295-05DBAAA3-FC9B-49DD-AF90-BC3E3899DF4AQ33564111-7A0B58A1-AE9F-4CCD-B4A8-9BEE3DD1FFD5Q34044661-91608EE7-3364-43E1-A630-67AE5DB1AFC9Q34221765-22219F47-992D-48E2-ABBC-B02691806FECQ34585093-7ED5BEF2-AB97-4BD0-A3AB-C6225BD91630Q34661887-C9CEC46C-2FDE-42AC-85EC-D2E4D5832CB6Q35024542-C7EAACA6-E03C-4B20-9636-F13DD4A07613Q35741383-D41090C5-8E23-4E52-AC0D-392E95034556Q36856318-2465E76E-E19D-4C8E-841A-2388FC6E59AFQ36867985-0A537A58-D458-46EB-A3A4-79082EF9BA89Q37000936-88E922AD-DD8F-464C-94D7-37222010F4E8Q37374618-6D826285-5040-4F15-BCD2-B4F23392D348Q37424550-E92B8E2E-C291-4A05-8AA0-CD322AC97F65Q37865169-3253EA57-851E-42D1-8116-E7D01C225A12Q38121955-D1ECA211-44E6-475A-AF8C-934A0F240179Q39624414-4181E270-784A-499F-BDE2-2DCFF902FCE2Q40052370-02CA3D79-ADF1-4FF6-8DFA-8D4A0C2D5422Q40176046-A9E7D3BD-D366-46E3-92EF-D79E2AEE0B68Q40375288-9C3CF08A-6C85-495C-9D1E-8929A6362DB6Q42021055-AB5FA23A-D935-4889-BB8B-EA4B72E77AF3Q42461070-15AB9640-9827-42E5-A5D0-C10A67CA0659Q44189097-1EA04A18-9B1F-4C8D-9B62-79D250A77C8BQ45316828-61C4CE05-44C8-4F0B-8ED3-C719A69BCEF1Q45871170-0DB1A959-889A-4C0D-A648-C5D4D657C841Q48428199-58375402-C84A-4880-B9F9-C917546DE294Q50053674-AAA460F7-249C-475A-BE5D-E9E4E539D908Q53629368-C64DA0FE-389A-46FD-A6B0-38A6259D8FE6
P2860
CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@ast
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@en
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@nl
type
label
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@ast
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@en
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@nl
prefLabel
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@ast
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@en
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@nl
P2860
P356
P1433
P1476
CpG methylation of the FHIT, F ...... umors (GCTs) of ovarian origin
@en
P2093
Mohd Shahid
Varinderpal S Dhillon
P2860
P2888
P356
10.1186/1476-4598-3-33
P407
P577
2004-12-01T00:00:00Z
P5875
P6179
1006919026